ISSN 0975-3583

Journal of Cardiovascular Disease Research

    Patients with heart failure and reduced ejection fraction after sacubitril/valsartan treatment may be at risk for major adverse cardiovascular events according to ΔRDW.

    Shashi Bhusan Sutar, Jitendra Naik, Gouri Oram, Desabandhu Behera
    JCDR. 2024: 601-608


    The objective of this study was to assess the correlation between alterations in the distribution width of red blood cells (RDW) and the incidence of major adverse cardiovascular events (MACEs) in patients with heart failure with reduced ejection fraction (HFRF) receiving sacubitril/valsartan therapy



    » PDF

    Volume & Issue

    Volume 15 Issue 3